Karlowsky, James - University of Manitoba - Department of Medical Microbiology and Infectious Diseases

研究领域

Antimicrobial resistance, diagnostic clinical microbiology

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Simner PJ, Gilmour MW, DeGagne P, Nichol KA, Karlowsky JA. Evaluation of five chromogenic media and the ROSCO Rapid CARB Screen kit for detection and confirmation of carbapenemase production in gram-negative bacilli. Journal of Clinical Microbiology, 2015;53(1):105-112. Zhanel GG, Love R, Adam H, Golden A, Zelenitsky S, Schweizer F, Gorityala B, Lagacé-Wiens PRS, Rubinstein E, Walkty A, Gin AS, Gilmour M, Hoban DJ, Lynch JP, Karlowsky JA. Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens. Drugs, 2015;75(3):253-270. Karlowsky JA, Walkty A, Adam HJ, Baxter MR, Zhanel GG. In vitro activity of oritavancin against gram-positive pathogens isolated in Canadian hospitals from 2011 to 2013. Diagnostic Microbiology and Infectious Disease, 2014;80(4):311-315. Zhanel GG, Wolter KD, Calciu C, Hogan P, Low DE, Weiss K, Karlowsky JA. Clinical cure rates in subjects treated with azithromycin for community-acquired respiratory tract infections caused by azithromycin-susceptible or azithromycin-resistant Streptococcus pneumoniae: analysis of phase 3 clinical trial data. Journal of Antimicrobial Chemotherapy, 2014;69(10):2835-2840. Karlowsky JA, Denisuik AJ, Lagacé-Wiens PRS, Adam HJ, Baxter MR, Hoban DJ, Zhanel GG. In vitro activity of fosfomycin against Escherichia coli isolated from patients with urinary tract infections in Canada as part of the CANWARD surveillance study. Antimicrobial Agents and Chemotherapy, 2014;58(2):1252-1256.